Factors associated with lymph node assessment in ductal carcinoma in situ: Analysis of 1988-2002 seer data

Annals of Surgical Oncology

Volumn 15, Issue 10, 2008, Pages 2709-2719

  Porembka, Matthew R ^a   Abraham, Rebecca L ^b   Sefko, Julianne A ^b   Deshpande, Anjali D ^b,c   Jeffe, Donna B ^a,c   Margenthaler, Julie A ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c USA   (United States)

Author keywords

Axillary lymph node dissection; Ductal carcinoma in situ; Sentinel lymph node biopsy; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CONSERVATION THERAPY; BREAST SURGERY; CANCER GRADING; CANCER RISK; CARCINOMA IN SITU; CASE CONTROL STUDY; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DUCTAL CARCINOMA IN SITU; FEMALE; HUMAN; LYMPH NODE ASSESSMENT; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; NEOPLASM INVASIVENESS; ODDS RATIO; PROGNOSIS; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS;

EID: 51649099956     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9947-5     Document Type: Article

References (46)

1. VL Ernster J Barclay K Kerlikowske 1996 Incidence of and treatment for ductal carcinoma in situ of the breast JAMA 275 913 8
2. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI, Consensus Conference Committee. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer 2000; 88:946-54
3. VL Ernster J Barclay K Kerlikowske 2000 Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program Arch Intern Med 160 953 8
4. B Fisher J Bryant N Wolmark 1998 Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 2672 85
5. B Fisher JP Costantino DL Wickerham 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1371 88
6. B Fisher J Dignam N Wolmark 1999 Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 353 1993 2000
7. JP Julien N Bijker IS Fentiman 2000 Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group Lancet 355 528 33
8. ES Fisher HG Welch 1999 Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA 281 446 53
9. M Morrow L Venta T Stinson 2001 Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients Ann Surg 233 537 41
10. ML Darling DN Smith SC Lester 2000 Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision AJR Am J Roentgenol 175 1341 6
11. MJ Silverstein MD Lagios A Recht 2005 Image-detected breast cancer: state of the art diagnosis and treatment J Am Coll Surg 201 586 97
12. LE Hoorntje PH Peeters WP Mali 2004 Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions? Breast Cancer Res Treat 86 165 70
13. TW Yen KK Hunt MI Ross 2005 Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ J Am Coll Surg 200 516 26
14. L Liberman 2000 Clinical management issues in percutaneous core breast biopsy Radiol Clin North Am 38 791 807
15. L Liberman M Drotman EA Morris 2000 Imaging-histologic discordance at percutaneous breast biopsy Cancer 89 2538 46
16. RJ Jackman F Burbank SH Parker 2001 Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates Radiology 218 497 502
17. RJ Jackman KW Nowels J Rodriguez-Soto 1999 Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up Radiology 210 799 805
18. LE Hoorntje ME Schipper PH Peeters 2003 The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy Ann Surg Oncol 10 748 53
19. S Pendas E Dauway R Giuliano 2000 Sentinel node biopsy in ductal carcinoma in situ patients Ann Surg Oncol 7 15 20
20. MJ Silverstein ED Gierson JR Waisman 1994 Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 73 664 7
21. P Veronesi M Intra AR Vento 2005 Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast 14 520 2
22. TA Kelly JA Kim R Patrick 2003 Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ Am J Surg 186 368 70
23. S Pendas J Jakub R Giuliano 2004 The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy Cancer Control 11 231 5
24. DJ Winchester HR Menck DP Winchester 1997 The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy Cancer 80 162 7
25. DJ Winchester HR Menck DP Winchester 1997 National treatment trends for ductal carcinoma in situ of the breast Arch Surg 132 660 5
26. DP Winchester HR Menck RT Osteen 1995 Treatment trends for ductal carcinoma in situ of the breast Ann Surg Oncol 2 207 13
27. DP Winchester RT Osteen HR Menck 1996 The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age Cancer 78 1838 43
28. NN Baxter BA Virnig SB Durham 2004 Trends in the treatment of ductal carcinoma in situ of the breast J Natl Cancer Inst 96 443 8
29. MJ Silverstein KA Skinner TJ Lomis 2001 Predicting axillary nodal positivity in 2282 patients with breast carcinoma World J Surg 25 767 72
30. GD Leonard SM Swain 2004 Ductal carcinoma in situ, complexities and challenges J Natl Cancer Inst 96 906 20
31. RG Parker D Berkbigler K Rees 1998 Axillary node dissection in ductal carcinoma in situ Am J Clin Oncol 21 109 10
32. PR Kitchen JN Cawson CM Krishnan 2000 Axillary dissection and ductal carcinoma in situ of the breast: a change in practice Aust N Z J Surg 70 419 22
33. GH Sakorafas DR Farley 2003 Optimal management of ductal carcinoma in situ of the breast Surg Oncol 12 221 40
34. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ 1998; 158(Suppl 3):S27-34
35. RW Carlson B McCormick 2005 Update: NCCN breast cancer Clinical Practice Guidelines J Natl Compr Canc Netw 3 Suppl 1 S7 11
36. AM Leitch GD Dodd M Costanza 1997 American Cancer Society guidelines for the early detection of breast cancer: Update 1997 CA Cancer J Clin 47 150 3
37. U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002; 137:344-7
38. J Gralow RF Ozols DF Bajorin 2008 Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology J Clin Oncol 26 313 25
39. JA Pagan DA Asch CJ Brown 2008 Lack of community insurance and mammography screening rates among insured and uninsured women J Clin Oncol 26 1865 70
40. A Partridge K Adloff E Blood 2008 Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study J Natl Cancer Inst 100 243 51
41. HS Cody 2007 Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions J Surg Oncol 95 440 2
42. MD Lagios MJ Silverstein 2001 Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction Ann Surg Oncol 8 275 7
43. S Pendas E Dauway R Giuliano 2000 Sentinel node biopsy in ductal carcinoma in situ patients Ann Surg Oncol 7 15 20
44. M Leidenius K Salmenkivi K Von Smitten 2006 Tumour-positive sentinel node findings in patients with ductal carcinoma in situ J Surg Oncol 94 380 4
45. C Tunon-de-Lara S Giard M Buttarelli 2008 Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy Breast J 14 135 40
46. FJ Dominguez M Golshan DM Black 2008 Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ Ann Surg Oncol 15 268 73